ENSC
Ensysce Biosciences, Inc.
Key Financials
Revenue
$5.1M
↓ 2.8%
Operating Income
$-10240946
↓ 52.2%
Net Income
$2.4M
↑ 557.1%
Total Assets
$7.5M
↑ 33.1%
EPS (Diluted)
$-3.98
↑ 65.2%
Cash & Equivalents
$4.3M
↑ 23.1%
Shareholders' Equity
$3.2M
↓ 13.3%
Total Liabilities
$4.6M
↑ 106.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ENSC |
| Company Name | Ensysce Biosciences, Inc. |
| CIK | 1716947 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (858) 263-4196 |